Compound information
- Natural Products
- ZC2566859
- Molecular Formula
- C11H8BrF6NO
- Molecular Weight
- 362.969345296 g/mol
- Structure
-
- IUPAC Name
- (2R)-N-[3,5-bis(trifluoromethyl)phenyl]-2-bromo-propanamide
- InChI
- InChI=1S/C11H8BrF6NO/c1-5(12)9(20)19-8-3-6(10(13,14)15)2-7(4-8)11(16,17)18/h2-5H,1H3,(H,19,20)/t5-/m1/s1
- InChI Key
- PCESRJVCFUAIBU-RXMQYKEDSA-N
- SMILES
- C[C@@H](Br)C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1
- Source
- ZINC000002577643
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 1 |
Heteroatom Count | 9 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 1 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 29.1 Å2 | LogP | 4.075 |
LogS | -5.343 | LogD | 4.111 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.198 | Pgp substrate | 0.049 |
HIA | 0.977 | F20 % | 0.968 |
F30 % | 0.964 | Caco-2 | -4.794 |
MDCK | -4.853 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.065 | PPB | 95.796 |
VD | 3.94 | Fu | 2.124 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.982 | CYP1A2 substrate | 0.585 |
CYP2A6 substrate | 0.793 | CYP2B6 substrate | 0.274 |
CYP2C19 inhibitor | 0.654 | CYP2C19 substrate | 0.601 |
CYP2C8 substrate | 0.238 | CYP2C9 inhibitor | 0.54 |
CYP2C9 substrate | 0.014 | CYP2D6 inhibitor | 0.564 |
CYP2D6 substrate | 0.092 | CYP2E1 substrate | 0.464 |
CYP3A4 inhibitor | 0.733 | CYP3A4 substrate | 0.989 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.068 | CL | 12.159 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.015 | Hepatotoxicity | 0.999 |
Mutagenicity | 0.228 | Rat Oral Acute Toxicity | 0.347 |
FDAMDD | 0.68 | Skin Sensitization | 0.025 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.354 |
Eye Irritation | 0.53 | Respiratory Toxicity | 0.879 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.318 | IGC50 | 4.047 |
LC50FM | 5.407 | LC50DM | 7.921 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.385 | NR-AR-LBD | 0.35 |
NR-AhR | 0.387 | NR-Aromatase | 0.216 |
NR-ER | 0.364 | NR-ER-LBD | 0.425 |
NR-PPAR-gamma | 0.813 | SR-ARE | 0.363 |
SR-ATAD5 | 0.381 | SR-HSE | 0.059 |
SR-MMP | 0.611 | SR-p53 | 0.756 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.